Sapiens International (SPNS) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
Regencell Bioscience (RGC) | 14,061.68% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,469.2% |
Cidara Therapeutics (CDTX) | 712.8% |
Celcuity LLC (CELC) | 650.08% |
Terns Pharmaceuticals (TERN) | 606.03% |
Sandisk (SNDK) | 525.96% |
TMC the metals (TMC) | 507.02% |
Olema Pharmaceuticals (OLMA) | 420.44% |
GRAIL, LLC (GRAL) | 395.59% |
Cogent Biosciences (COGT) | 379.75% |
Aris Mining (ARMN) | 340.85% |
Aura Minerals Inc Common Shares (AUGO) | 337.25% |
Planet Labs PBC (PL) | 327.63% |
Sibanye Gold Ltd ADR (SBSW) | 307.92% |
Opendoor Technologies (OPEN) | 286.46% |
ViaSat (VSAT) | 267.95% |
Arrowhead Pharmaceuticals (ARWR) | 250.95% |
Praxis Precision Medicines (PRAX) | 246.45% |
DRDGOLD Limited ADR (DRD) | 242.3% |
Centrus Energy (LEU) | 240.17% |
CommScope (COMM) | 239.35% |
Nuvation Bio (NUVB) | 235.45% |
New Gold (NGD) | 232.67% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
